• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PVT1 是与膀胱尿路上皮癌免疫浸润相关的预后标志物。

PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma.

机构信息

Department of General Surgery, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin 300052, China.

Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, No. 218, Jixi Road, Shushan District, Hefei 230022, China.

出版信息

Math Biosci Eng. 2022 Jan;19(1):169-190. doi: 10.3934/mbe.2022009. Epub 2021 Nov 9.

DOI:10.3934/mbe.2022009
PMID:34902986
Abstract

Plasmacytoma variant translocation 1 (PVT1) is involved in multiple signaling pathways and plays an important regulatory role in a variety of malignant tumors. However, its role in the prognosis and immune invasion of bladder urothelial carcinoma (BLCA) remains unclear. This study investigated the expression of PVT1 in tumor tissue and its relationship with immune invasion, and determined its prognostic role in patients with BLCA. Patients were identified from the cancer genome atlas (TCGA). The enrichment pathway and function of PVT1 were explained by gene ontology (GO) term analysis, gene set enrichment analysis (GSEA) and single-sample gene set enrichment analysis (ssGSEA), and the degree of immune cell infiltration was quantified. Kaplan-Meier analysis and Cox regression were used to analyze the correlation between PVT1 and survival rate. PVT1-high BLCA patients had a lower 10-year disease-specific survival (DSS P < 0.05) and overall survival (OS P < 0.05). Multivariate Cox regression analysis showed that PVT1 (high vs. low) (P = 0.004) was an independent prognostic factor. A nomogram was used to predict the effect of PVT1 on the prognosis. PVT1 plays an important role in the progression and prognosis of BLCA and can be used as a medium biomarker to predict survival after cystectomy.

摘要

浆细胞瘤变异易位 1(PVT1)参与多种信号通路,在多种恶性肿瘤中发挥重要的调控作用。然而,其在膀胱尿路上皮癌(BLCA)中的预后和免疫浸润作用尚不清楚。本研究探讨了 PVT1 在肿瘤组织中的表达及其与免疫浸润的关系,并确定了其在 BLCA 患者预后中的作用。患者从癌症基因组图谱(TCGA)中确定。通过基因本体论(GO)术语分析、基因集富集分析(GSEA)和单样本基因集富集分析(ssGSEA)解释 PVT1 的富集途径和功能,并量化免疫细胞浸润程度。Kaplan-Meier 分析和 Cox 回归用于分析 PVT1 与生存率之间的相关性。PVT1 高表达的 BLCA 患者的 10 年疾病特异性生存率(DSS,P < 0.05)和总生存率(OS,P < 0.05)均较低。多因素 Cox 回归分析表明,PVT1(高 vs. 低)(P = 0.004)是独立的预后因素。使用列线图预测 PVT1 对预后的影响。PVT1 在 BLCA 的进展和预后中发挥重要作用,可作为一种中等生物标志物,用于预测膀胱切除术的生存情况。

相似文献

1
PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma.PVT1 是与膀胱尿路上皮癌免疫浸润相关的预后标志物。
Math Biosci Eng. 2022 Jan;19(1):169-190. doi: 10.3934/mbe.2022009. Epub 2021 Nov 9.
2
KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma.KLK6 在膀胱尿路上皮癌中作为癌基因和不良预后因素发挥作用。
Dis Markers. 2022 Sep 22;2022:3373851. doi: 10.1155/2022/3373851. eCollection 2022.
3
Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.基于无附著凋亡相关基因特征的 BLCA 预后模型的建立:初步研究结果。
BMC Urol. 2023 Dec 4;23(1):199. doi: 10.1186/s12894-023-01382-8.
4
Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.膀胱癌中 Wnt 通路相关的三信使 RNA 临床预后特征:计算生物学和实验分析。
J Transl Med. 2021 Sep 27;19(1):409. doi: 10.1186/s12967-021-03061-4.
5
Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.揭示淋巴结转移相关异常甲基化差异表达基因的潜在功能及其与膀胱癌免疫浸润和预后的关系。
PeerJ. 2023 Apr 24;11:e15284. doi: 10.7717/peerj.15284. eCollection 2023.
6
Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.基于坏死性细胞凋亡相关 lncRNAs 预测膀胱癌预后和鉴别冷肿瘤和热肿瘤。
Front Immunol. 2022 Jul 4;13:916800. doi: 10.3389/fimmu.2022.916800. eCollection 2022.
7
miR-628-5p is a Potential Novel Prognosis Biomarker, Associated with Immune Infiltration in Bladder Urothelial Carcinoma.miR-628-5p 是膀胱癌潜在的新型预后生物标志物,与免疫浸润相关。
Curr Pharm Des. 2023;29(31):2477-2488. doi: 10.2174/0113816128254621231017062923.
8
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.基于免疫基因分析构建和验证与膀胱尿路上皮癌相关的基因特征。
BMC Cancer. 2022 Aug 27;22(1):926. doi: 10.1186/s12885-022-09794-9.
9
MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.MTHFD2 是一种潜在的致癌基因,因为它与膀胱癌的不良预后和高水平的免疫浸润密切相关。
BMC Cancer. 2022 May 17;22(1):556. doi: 10.1186/s12885-022-09606-0.
10
Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.COL10A1 在尿路上皮膀胱癌中的预后价值及其与肿瘤浸润免疫细胞的相关性:基于生物信息学和临床分析验证的综合研究。
Front Immunol. 2023 Mar 17;14:955949. doi: 10.3389/fimmu.2023.955949. eCollection 2023.